Skip to main content
. Author manuscript; available in PMC: 2013 Mar 1.
Published in final edited form as: Bone. 2011 Dec 10;50(3):743–748. doi: 10.1016/j.bone.2011.12.001

Table 1.

Baseline characteristics of study subjects. Values are given as Mean (SD).

Men (N = 111) Women (N = 112)
Age (years) 76.7 (5.6) 77.0 (5.11)
Height (cm) 176.0 (6.5) 160.0 (5.6) ****
Weight (kg) 81.3 (13.8) 69.4 (10.7) ****
Health Status 2.46 (0.11) 2.55 (0.11)
# Subjects on bone-altering medications 20 61
FFall (N) 1690 (670) 1200 (463) ****
FStance (N) 10300 (2920) 7710 (2060) ****
aBMD (g/cm2) 0.822 (0.169) 0.687 (0.141)****
tBMD (g/cm3) 0.078 (0.038) 0.064 (0.033) **
cvol/ivol 0.342 (0.046) 0.338 (0.050)

p-values for gender differences based on Mann-Whitney test

*

: p<0.05

**

: p<0.01

****

p<0.0001